No Data
The CRO Sector is under pressure, WUXI BIO (02269) fell 6.73% as it is rumored that the USA intends to restrict investments by Chinese enterprises in several strategic areas.
Kingwu Financial News | The CRO Sector is under pressure, WUXI BIO (02269) fell by 6.73%, WUXI APPTEC (02359) fell by 5.57%, VIVA BIOTECH (01873) fell by 3.77%, TIGERMED (03347) fell by 3.5%, PHARMARON (03759) fell by 3.12%. According to media reports citing anonymous USA officials, President Trump signed an order directing the Treasury Department's Committee on Foreign Investment in the USA (CFIUS) to continue restricting Chinese companies from making investments in several strategic sectors in the USA. Reports indicate that the purpose of the memorandum is to ensure USA National Security while requiring
Trending Industry Today: TIGERMED Leads Gains In CRO Stocks
In half a month, the stock price has increased by 85%. Can DeepSeek truly become a catalyst for VIVA BIOTECH (01873) to overtake in a curve?
After nearly four months of sideways movement, VIVA BIOTECH began to show signs of a rising stock price starting in February of this year, with a consecutive five-day positive trend from February 6 to 12. However, the explosion of the AI Medical Concept seems to have catalyzed this market trend into a significant surge. By February 19, VIVA BIOTECH had achieved a stock price increase of 85% in February.
China Merchants: The blue ocean of AI in pharmaceuticals, with AI assisting the entire process of new drug development.
Previously, the application of AI technology in the drug development process mainly focused on the drug discovery stage. With the application of large model technologies like Deepseek, the value of AI in the clinical stage will gradually become evident.
Hong Kong stocks movement | VIVA BIOTECH (01873) once rose over 15%. The company locally deploys the DeepSee model, and the AIDD/CADD platform continues to make breakthroughs.
VIVA BIOTECH (01873) once rose over 15%. It is noteworthy that the stock has continued to climb recently, with an increase of up to 80% this month. As of the time of writing, it has risen 10.61%, priced at HKD 1.46, with a transaction volume of HKD 26.0754 million.
Hong Kong stocks fluctuated | CRO Concept stocks continued to surge in the morning, WUXI BIO (02269) and TIGERMED (03347) both rose over 9%.
In the early session, CRO Concept stocks continued to rise. As of the time of writing, WUXI BIO (02269) is up 9.59%, priced at 22.85 HKD; TIGERMED (03347) is up 9.09%, priced at 31.2 HKD; GENSCRIPT BIO (01548) is up 7.22%, priced at 11.88 HKD.
